Header Logo

Connection

Jennifer Smit to Norethindrone

This is a "connection" page, showing publications Jennifer Smit has written about Norethindrone.
Connection Strength

1,188
  1. The injectable contraceptives depot medroxyprogesterone acetate and norethisterone enanthate substantially and differentially decrease testosterone and sex hormone binding globulin levels: A secondary study from the WHICH randomized clinical trial. PLoS One. 2024; 19(8):e0307736.
    View in: PubMed
    Score: 0,232
  2. Effects of injectable contraception with depot medroxyprogesterone acetate or norethisterone enanthate on estradiol levels and menstrual, psychological and behavioral measures relevant to HIV risk: The WHICH randomized trial. PLoS One. 2024; 19(3):e0295764.
    View in: PubMed
    Score: 0,225
  3. Vaginal wetness: an underestimated problem experienced by progestogen injectable contraceptive users in South Africa. Soc Sci Med. 2002 Nov; 55(9):1511-22.
    View in: PubMed
    Score: 0,204
  4. Assessing menopausal status in women aged 40 - 49 using depot-medroxyprogesterone acetate, norethisterone enanthate or combined oral contraception. S Afr Med J. 2011 Feb; 101(2):131-5.
    View in: PubMed
    Score: 0,091
  5. Prospective study of weight change in new adolescent users of DMPA, NET-EN, COCs, nonusers and discontinuers of hormonal contraception. Contraception. 2010 Jan; 81(1):30-4.
    View in: PubMed
    Score: 0,084
  6. Bone mineral density in young women aged 19-24 after 4-5 years of exclusive and mixed use of hormonal contraception. Contraception. 2009 Aug; 80(2):128-32.
    View in: PubMed
    Score: 0,079
  7. Bone mineral density in a cohort of adolescents during use of norethisterone enanthate, depot-medroxyprogesterone acetate or combined oral contraceptives and after discontinuation of norethisterone enanthate. Contraception. 2009 May; 79(5):345-9.
    View in: PubMed
    Score: 0,079
  8. Bone mineral density in adolescents using norethisterone enanthate, depot-medroxyprogesterone acetate or combined oral contraceptives for contraception. Contraception. 2007 Jun; 75(6):438-43.
    View in: PubMed
    Score: 0,069
  9. Misreporting contraceptive use and the association of peak study progestin levels with weight and BMI among women randomized to the progestin-only injectable contraceptives DMPA-IM and NET-EN. PLoS One. 2023; 18(12):e0295959.
    View in: PubMed
    Score: 0,055
  10. Detection of raised FSH levels among older women using depomedroxyprogesterone acetate and norethisterone enanthate. Contraception. 2003 Nov; 68(5):339-43.
    View in: PubMed
    Score: 0,055
  11. Bone mineral density in women aged 40-49 years using depot-medroxyprogesterone acetate, norethisterone enanthate or combined oral contraceptives for contraception. Contraception. 2005 Mar; 71(3):170-5.
    View in: PubMed
    Score: 0,015
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.